Your account is not claimed yet. You can sign up with ORCID to claim your account.

Andrew N Holding (Andrew Holding)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 6

Top Venues

Genome biology

eLife

Science translational medicine

Bioscience reports

University of York

University of Cambridge (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of York Sep 16o 2019

United Kingdom

Lecturer in Biomedical Sciences :: Biology

Education History

University of Cambridge Oct 1o 2005 - Oct 1o 2009

United Kingdom

PHD :: Deparment of Chemistry

Publications

Andrew N Holding, Kirsty R McIntyre, Paul T Lynch
Is it possible to measure good science? The FEBS journal (2022)
Daniele Mercatelli, Francesco Formaggio, Marco Caprini, Andrew N Holding, Federico Manuel Giorgi
Detection of subtype-specific breast cancer surface protein biomarkers via a novel transcriptomics approach. Bioscience reports 41 (12) (2022)
Andrew N Holding, Federico M Giorgi, Amanda Donnelly, Amy E Cullen, Sankari Nagarajan, Luke A Selth, Florian Markowetz
VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer. Genome biology 20 (1) (2019)
Euan S Polson, Verena B Kuchler, Christopher Abbosh, Edith M Ross, Ryan Koshy Mathew, Hester A Beard, Bárbara da Silva, Andrew N Holding, Stephane Ballereau, Eulashini Chuntharpursat-Bon, Jennifer Williams, Hollie B S Griffiths, Hao Shao, Anjana Patel, Adam J Davies, Alastair P Droop, Paul Chumas, Susan C Short, Mihaela Lorger, Jason E Gestwicki, Lee D Roberts, Robin S Bon, Simon J Allison, Shoutian Zhu, Florian Markowetz, Heiko Wurdak
KHS101 disrupts energy metabolism in human glioblastoma cells and reduces tumor growth in mice. Science translational medicine 10 (454) (2019)
Andrew N Holding, Federico M Giorgi, Amanda Donnelly, Amy E Cullen, Sankari Nagarajan, Luke A Selth, Florian Markowetz
Correction to: VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer. Genome biology 20 (1) (2019)
Andrew N Holding, Amy E Cullen, Florian Markowetz
Genome-wide Estrogen Receptor-α activation is sustained, not cyclical. eLife 7 (2018)

Andrew N Holding.css-eqlu8i{font-size:small;padding-left:4px;} (Andrew Holding)

Publication Activity (10 Years)

Top Topics

Top Venues

Andrew N Holding (Andrew Holding)